Clinical significance of transmembrane 4 superfamily in colon cancer.
about
Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cellsMetastasis suppressor genesCD151-A Striking Marker for Cancer TherapyTetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysisScreening and cloning for proteins transactivated by the PS1TP5 protein of hepatitis B virus: a suppression subtractive hybridization studyA critical role for tetraspanin CD151 in alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions on laminin-5Molecular epidemiological study on pre-X region of hepatitis B virus and identification of hepatocyte proteins interacting with whole-X protein by yeast two-hybridLaminin-binding integrins and their tetraspanin partners as potential antimetastatic targets.The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth.Structure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by α3β1 versus α6β4 integrin.Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling.Down-regulation of CD9 by methylation decreased bortezomib sensitivity in multiple myeloma.KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinomaClinical significance of CD151 overexpression in subtypes of invasive breast cancer.Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinomaTetraspanin CD151 stimulates adhesion-dependent activation of Ras, Rac, and Cdc42 by facilitating molecular association between β1 integrins and small GTPasesExosomal secretion of cytoplasmic prostate cancer xenograft-derived proteins.Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification.Cell surface markers in colorectal cancer prognosis.Tetraspanin CD151 as a target for antibody-based cancer immunotherapy.Metastasis-suppressor genes in clinical practice: lost in translation?CD151 in cancer progression and metastasis: a complex scenario.CD151 expression can predict cancer progression in clear cell renal cell carcinoma.Targeting CD151 by lentivirus-mediated RNA interference inhibits luminal and basal-like breast cancer cell growth and invasion.α3β1 integrins regulate CD151 complex assembly and membrane dynamics in carcinoma cells within 3D environments.CD151 promotes proliferation and migration of PC3 cells via the formation of CD151-integrin α3/α6 complex.Expression of KITENIN in human colorectal cancer and its relation to tumor behavior and progression.CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma.The tetraspanin CD151 regulates cell morphology and intracellular signaling on laminin-511.Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways.Role of KAI1/CD82 polymorphisms in colon cancer risk in Han Chinese population.Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies.CD151 Expression Is Associated with a Hyperproliferative T Cell Phenotype.Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.Expression of cluster of differentiation 151 prior to and following transcatheter arterial chemoembolization therapy in patients with hepatocellular carcinoma and its association with clinicopathological characteristics.CD151 overexpression is associated with poor prognosis in patients with pT3 gastric cancer.
P2860
Q24792777-7A23A692-985C-45C5-AAC0-FB1C74D607AAQ26866948-0AF96956-B160-48A1-9230-71A69B840796Q27024979-A82B9809-5653-4058-8005-C7692BC1B8EAQ28071547-7B7D6FC4-AFA6-4343-915F-DA21B5068E86Q28299559-B08E776A-A4B8-4D0D-A00A-84BF25E5B8DEQ30477393-5C3690B0-568B-4CA4-92C6-000E3BC30CC3Q33216835-A6E9F8DD-E077-4482-AF1F-FB81503168D5Q33610587-2D6A80F8-2E5F-47BF-B979-4B11BE96DFBAQ34386024-290B63D4-5588-4087-92B0-C4DE0FC2499EQ34606382-F5FF7B70-1BD5-45B8-ADF1-7800D41A37E8Q34914039-40D419D2-1BBF-4C52-8167-34A36397A8D1Q35067887-7017E5E5-E64A-4941-B35C-CE0E3EC6B5D4Q35161600-A7C7D622-4656-4DDA-AACD-0F037854B360Q35550219-E003C0EE-ABB3-4FE0-BEFE-65374AEE0A9FQ35632281-4AE12743-F63E-41E2-9CAA-A77500B670CDQ35837603-ADD33CE9-AF2B-44A9-B39A-8B68B3EDD933Q36092648-7A1EC161-2D1B-48EC-B208-3BD416F0DAE6Q36234770-3430A4AD-7B0E-4EAA-B556-0E74FF9A93A2Q37212412-327B9B0E-C1BE-41BC-8F8F-6B43CAAEFD05Q37395986-2BC4014B-70BA-40A4-A647-719FAAB58452Q37845669-5FF9836F-03ED-414D-97DD-4FB1E2E3C0FAQ37856399-3A574C8F-6612-4719-9E82-36E32315688BQ37869335-815C9042-2080-4258-9DBB-C1E0C2FC40B2Q38163831-E2965E0B-4290-495E-839D-90229C684327Q38477056-7054F435-AE65-483F-AD2E-3C34FE23A252Q38871638-6CA055DD-90A3-419D-AFFB-1202A0CFA639Q39276841-58F49F19-5131-4543-A3BD-B86287FA6C15Q39333843-21BF4C00-824E-4283-B19F-5D0386C69DB5Q39574037-701B6321-2ACD-485C-A3E2-1AC2EC85A962Q39574076-15397DE7-7142-4714-815F-26B25CC11624Q39733170-DBBEE109-A69C-46EC-9E2B-18484266D03CQ39907568-9CD6E3F8-D4CA-4D42-B2D2-0AA4950CC769Q39980373-C7988C96-D19F-4B9F-BC61-5B68C2533E0CQ40263014-BB9714F8-DC30-4249-B2AA-9DE2239899FCQ43970936-75DA2E07-2E16-465A-9C47-9E87ECDE9E2BQ47112838-544C69CE-B5C2-40C0-B9F8-E16E47D06223Q47734831-5E12463D-7061-4C8D-8E60-D5F389313D1DQ48397324-2E5A05E3-E59C-4180-9608-54CE024A3D1CQ49386865-0452A76C-B97E-4B0B-8220-326BFA86534EQ51768747-4571CA74-B4EA-46D4-831F-EC2EDF386062
P2860
Clinical significance of transmembrane 4 superfamily in colon cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Clinical significance of transmembrane 4 superfamily in colon cancer.
@ast
Clinical significance of transmembrane 4 superfamily in colon cancer.
@en
type
label
Clinical significance of transmembrane 4 superfamily in colon cancer.
@ast
Clinical significance of transmembrane 4 superfamily in colon cancer.
@en
prefLabel
Clinical significance of transmembrane 4 superfamily in colon cancer.
@ast
Clinical significance of transmembrane 4 superfamily in colon cancer.
@en
P2093
P2860
P356
P1476
Clinical significance of transmembrane 4 superfamily in colon cancer.
@en
P2093
A Takabayashi
H Hasegawa
N Kobayashi
T Tokuhara
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601015
P407
P577
2003-07-01T00:00:00Z
P5875
P6179
1003573546